Literature DB >> 27277168

Reverse atrial remodeling in patients who maintain sinus rhythm after electrical cardioversion: evidence derived from the measurement of total atrial conduction time assessed by PA-TDI interval.

Patrick Müller1,2, Fabian Schiedat3, Johannes-Wolfgang Dietrich4, Dong-In Shin5, Kaffer Kara3, Andreas Mügge3, Thomas Deneke3,6.   

Abstract

BACKGROUND: A key mechanism of atrial fibrillation (AF) is atrial remodeling. Total atrial conduction time non-invasively assessed via tissue Doppler imaging (PA-TDI interval) may reflect the degree of electrical and structural atrial remodeling. The purpose of this study was to determine whether the PA-TDI interval is an independent predictor of recurrent AF after successful electrical cardioversion (eCV) and if it suggests reverse atrial remodeling.
METHODS: Fifty-one patients (mean ± SD 66 ± 10.6 years; 35 % women) with persistent AF and successful eCV were prospectively enrolled. The PA-TDI interval was measured 6 h and 90 days post-cardioversion. AF relapse was determined via 7-day Holter-ECG immediately after eCV and repeated after 90 days.
RESULTS: Early recurrent AF (within 7 days) occurred in 21 patients (41.2 %), whereas after 90-day follow-up 26 patients (51 %) had AF recurrence. PA-TDI interval was longer in patients with AF recurrence within 90 days compared to patients who remained in sinus rhythm (SR) (149.1 ± 8.3 vs. 129.8 ± 10.9 ms, p < 0.0001). Optimal cut-off values for recurrent AF after 7 or 90 days from ROC analysis were 142 and 143 ms, respectively. Furthermore, the PA-TDI interval decreased significantly from baseline in those who remained in SR (129.8 ± 10.9 vs. 125.8 ± 10 ms, p < 0.0001), whereas the PA-TDI interval increased in patients who developed AF after 90 days (149.1 ± 8.3 vs. 152 ± 9 ms, p < 0.0001).
CONCLUSIONS: The PA-TDI interval is an independent predictor of early and mid-term AF recurrence after eCV. Moreover, our data suggests reverse atrial remodeling in those patients who remained in stable SR.

Entities:  

Keywords:  Atrial fibrillation; Electrical cardioversion; PA-TDI interval; Reverse atrial remodeling

Mesh:

Year:  2014        PMID: 27277168     DOI: 10.1007/s12574-014-0227-z

Source DB:  PubMed          Journal:  J Echocardiogr        ISSN: 1349-0222


  20 in total

1.  Atrial activation time determined by transthoracic Doppler tissue imaging can be used as an estimate of the total duration of atrial electrical activation.

Authors:  Klaartje L Merckx; Cees B De Vos; Andrea Palmans; Jos Habets; Emile C Cheriex; Harry J G M Crijns; Robert G Tieleman
Journal:  J Am Soc Echocardiogr       Date:  2005-09       Impact factor: 5.251

Review 2.  New ideas about atrial fibrillation 50 years on.

Authors:  Stanley Nattel
Journal:  Nature       Date:  2002-01-10       Impact factor: 49.962

3.  Total atrial conduction time assessed by tissue doppler imaging (PA-TDI Interval) to predict early recurrence of persistent atrial fibrillation after successful electrical cardioversion.

Authors:  Patrick Müller; Fabian Schiedat; Anna Bialek; Leif Bösche; Aydan Ewers; Kaffer Kara; Johannes W Dietrich; Andreas Mügge; Thomas Deneke
Journal:  J Cardiovasc Electrophysiol       Date:  2013-11-14

4.  Reverse electrical remodeling of the atria post cardioversion in patients who remain in sinus rhythm assessed by signal averaging of the P-wave.

Authors:  Nagib Chalfoun; David Harnick; Elena Pe; Manish Undavia; Davendra Mehta; J Anthony Gomes
Journal:  Pacing Clin Electrophysiol       Date:  2007-04       Impact factor: 1.976

5.  Associations between the atrial electromechanical interval, atrial remodelling and outcome of catheter ablation in paroxysmal atrial fibrillation.

Authors:  Tze-Fan Chao; Shih-Hsien Sung; Kang-Ling Wang; Yenn-Jiang Lin; Shih-Lin Chang; Li-Wei Lo; Yu-Feng Hu; Ta-Chuan Tuan; Kazuyoshi Suenari; Cheng-Hung Li; Kuo-Chang Ueng; Tsu-Juey Wu; Shih-Ann Chen
Journal:  Heart       Date:  2010-12-13       Impact factor: 5.994

6.  Clinical correlates of immediate success and outcome at 1-year follow-up of real-world cardioversion of atrial fibrillation: the Euro Heart Survey.

Authors:  Ron Pisters; Robby Nieuwlaat; Martin H Prins; Jean-Yves Le Heuzey; Aldo P Maggioni; A John Camm; Harry J G M Crijns
Journal:  Europace       Date:  2012-01-05       Impact factor: 5.214

7.  Left atrial electromechanical conduction time can predict six-month maintenance of sinus rhythm after electrical cardioversion in persistent atrial fibrillation by Doppler tissue echocardiography.

Authors:  Seong-Mi Park; Yong-Hyun Kim; Jong-Il Choi; Hui-Nam Pak; Young-Hoon Kim; Wan-Joo Shim
Journal:  J Am Soc Echocardiogr       Date:  2010-03       Impact factor: 5.251

8.  Atrial tissue Doppler imaging for prediction of new-onset atrial fibrillation.

Authors:  C B De Vos; B Weijs; H J G M Crijns; E C Cheriex; A Palmans; J Habets; M H Prins; R Pisters; R Nieuwlaat; R G Tieleman
Journal:  Heart       Date:  2008-12-15       Impact factor: 5.994

9.  Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats.

Authors:  M C Wijffels; C J Kirchhof; R Dorland; M A Allessie
Journal:  Circulation       Date:  1995-10-01       Impact factor: 29.690

10.  Detection and quantification of left atrial structural remodeling with delayed-enhancement magnetic resonance imaging in patients with atrial fibrillation.

Authors:  Robert S Oakes; Troy J Badger; Eugene G Kholmovski; Nazem Akoum; Nathan S Burgon; Eric N Fish; Joshua J E Blauer; Swati N Rao; Edward V R DiBella; Nathan M Segerson; Marcos Daccarett; Jessiciah Windfelder; Christopher J McGann; Dennis Parker; Rob S MacLeod; Nassir F Marrouche
Journal:  Circulation       Date:  2009-03-23       Impact factor: 29.690

View more
  1 in total

Review 1.  Echocardiography-derived total atrial conduction time (PA-TDI duration): risk stratification and guidance in atrial fibrillation management.

Authors:  Patrick Müller; Bob Weijs; Nadine M A A Bemelmans; Andreas Mügge; Lars Eckardt; Harry J G M Crijns; Jeroen J Bax; Dominik Linz; Dennis W den Uijl
Journal:  Clin Res Cardiol       Date:  2021-08-28       Impact factor: 5.460

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.